Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D06HRD
|
|||
| Former ID |
DIB015111
|
|||
| Drug Name |
EUR-1100
|
|||
| Indication | Eosinophilic esophagitis [ICD-11: DA24.1; ICD-9: 530.13] | Phase 1/2 | [1] | |
| Company |
Aptalis Pharma Inc
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT01386112) Safety and Tolerability Study of Oral EUR-1100 to Treat Eosinophilic Esophagitis. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.